Abstract: The aim of dyslipidemia management is to reduce the risk of atherosclerotic cardiovascular disease.In recent years，changes have been taking place in the concept of dyslipidemia management for dyslipidemia management.However，there is no consensus on the monitoring targets for intervention in dyslipidemia management，control target，dyslipidemia risk grade and recommendations for statins among constantly updated national and international guidelines for the management of dyslipidemia.In order to achieve personalized treatment goals，based on the reviewing of the guidelines for the management of dyslipidemia and the associated new clinical studies，we suggest that the goal of dyslipidemia management should be set up in accordance with the multi-target monitoring results of the patient's conditions，and the reduction of control target should also be appropriate.

Key words: Cardiovascular diseases；Atherosclerosis；Dyslipidemias；Cholesterol, LDL；Dyslipidemia management

摘要： 血脂管理可以降低动脉粥样硬化性心血管疾病的风险。近年来，关于血脂异常的血脂管理理念正在转变。国内外的指南在持续更新，但对于血脂管理的监测靶目标、控制目标、风险等级、他汀类药物的推荐仍存在分歧。本文通过回顾国内外相关指南，结合最新临床研究进行分析，指出了血脂管理目标应根据患者具体情况多靶点监测，同时考虑控制目标的降低幅度，以达到个体化治疗。

关键词: 心血管疾病, 动脉粥样硬化, 血脂异常, 胆固醇, LDL, 血脂管理